Effective Phages as Green Antimicrobial Agents Against Antibiotic-Resistant Hospital Escherichia coli
Bacteriophages are viruses that attack bacteria and lead to their lysis in an efficient and highly specific manner. These natural enemies of bacteria were used as therapeutic agents before the advent of antibiotics. Currently, with the rapid spread of multi-drug resistant bacteria, phage therapy can...
Gespeichert in:
Veröffentlicht in: | Jundishapur journal of microbiology 2015-02, Vol.8 (2), p.e17744-e17744 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | e17744 |
---|---|
container_issue | 2 |
container_start_page | e17744 |
container_title | Jundishapur journal of microbiology |
container_volume | 8 |
creator | Rahmani, Rana Zarrini, Gholamreza Sheikhzadeh, Farzam Aghamohammadzadeh, Naser |
description | Bacteriophages are viruses that attack bacteria and lead to their lysis in an efficient and highly specific manner. These natural enemies of bacteria were used as therapeutic agents before the advent of antibiotics. Currently, with the rapid spread of multi-drug resistant bacteria, phage therapy can be an effective alternative treatment for antibiotic resistant bacteria.
This study evaluated the effectiveness of bacteriophages in removing antibiotic-resistant clinical Escherichia coli strains in vitro and in vivo.
Different samples were taken from bed sore and foot ulcers of patients with diabetes. E. coli strains were isolated and identified by standard methods. The antibiogram was ascertained using the Kirby Bauer disc diffusion method for ten antibiotics. The bacteriophages were isolated from environmental water samples. They were exposed to the host bacteria by the double-layer agar technique (DLA) to observe plaques. Cross reaction of the phages on test E. coli strains was performed to determine broader-spectrum phages. Phage TPR7 was selected for animal trials. Five groups of mice including a control group, bacterial group, phage group, antibiotic therapy group and phage therapy group, were examined.
Ten E. coli strains were isolated from hospital samples. They showed high resistance to the used antibiotics. An effective bacteriophage was isolated for each strain. The cross-reaction showed phages which affect more than six E. coli strains. They can be a good choice for clinical therapeutic use. In animal trials the group challenged with phages after being infected showed similar results as the group treated with gentamicin after being infected. In both groups infection was removed after 48 hours.
According to the results, six strains were resistant to six or seven antibiotics and all strains were at least resistant to two antibiotics. However, for each of these resistant bacteria one bacteriophage was isolated from environmental samples, which showed the effectiveness of bacteriophages to remove clinically resistant E. coli strains. Effective phages in vitro showed effective results in vivo as well. |
doi_str_mv | 10.5812/jjm.17744 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4377167</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3769510201</sourcerecordid><originalsourceid>FETCH-LOGICAL-c403t-fd27c41451fc9194e62117bbf4f68e8bdb5ad2f16d7bd40f0964432004028ade3</originalsourceid><addsrcrecordid>eNpdkU9rGzEQxUVpaUKaQ79AWeilPWyi0c5K8qVggpsUAgmhPQutdmTL7B9XkgP99pUTN7SdywzMj8ebeYy9B37RahCX2-14AUohvmKngnNdI0h4fZwbie0JO09pyw-luEbxlp2IVjeoQJwyWnlPLodHqu43dk2psqm6jkRTtZxyGIOLcxfsUC3XNOVUmg1Tyk_LLsw5uPqBUkjZTrm6mdMu5AKvkttQDG4TbOXmIbxjb7wdEp0f-xn78XX1_eqmvr27_na1vK0d8ibXvhfKIWAL3i1ggSQFgOo6j15q0l3ftbYXHmSvuh655wuJ2JRDkQtte2rO2Jdn3d2-G6l3xXK0g9nFMNr4y8w2mH83U9iY9fxosFEKpCoCn44Ccf65p5TNGJKjYbATzftkQMqFRg6oC_rxP3Q77-NUzjOgOJRAGn0Q_PxMlT-mFMm_mAFuDvmZkp95yq-wH_52_0L-Sav5Dc6klq4</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1701744387</pqid></control><display><type>article</type><title>Effective Phages as Green Antimicrobial Agents Against Antibiotic-Resistant Hospital Escherichia coli</title><source>PubMed Central Open Access</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Rahmani, Rana ; Zarrini, Gholamreza ; Sheikhzadeh, Farzam ; Aghamohammadzadeh, Naser</creator><creatorcontrib>Rahmani, Rana ; Zarrini, Gholamreza ; Sheikhzadeh, Farzam ; Aghamohammadzadeh, Naser</creatorcontrib><description>Bacteriophages are viruses that attack bacteria and lead to their lysis in an efficient and highly specific manner. These natural enemies of bacteria were used as therapeutic agents before the advent of antibiotics. Currently, with the rapid spread of multi-drug resistant bacteria, phage therapy can be an effective alternative treatment for antibiotic resistant bacteria.
This study evaluated the effectiveness of bacteriophages in removing antibiotic-resistant clinical Escherichia coli strains in vitro and in vivo.
Different samples were taken from bed sore and foot ulcers of patients with diabetes. E. coli strains were isolated and identified by standard methods. The antibiogram was ascertained using the Kirby Bauer disc diffusion method for ten antibiotics. The bacteriophages were isolated from environmental water samples. They were exposed to the host bacteria by the double-layer agar technique (DLA) to observe plaques. Cross reaction of the phages on test E. coli strains was performed to determine broader-spectrum phages. Phage TPR7 was selected for animal trials. Five groups of mice including a control group, bacterial group, phage group, antibiotic therapy group and phage therapy group, were examined.
Ten E. coli strains were isolated from hospital samples. They showed high resistance to the used antibiotics. An effective bacteriophage was isolated for each strain. The cross-reaction showed phages which affect more than six E. coli strains. They can be a good choice for clinical therapeutic use. In animal trials the group challenged with phages after being infected showed similar results as the group treated with gentamicin after being infected. In both groups infection was removed after 48 hours.
According to the results, six strains were resistant to six or seven antibiotics and all strains were at least resistant to two antibiotics. However, for each of these resistant bacteria one bacteriophage was isolated from environmental samples, which showed the effectiveness of bacteriophages to remove clinically resistant E. coli strains. Effective phages in vitro showed effective results in vivo as well.</description><identifier>ISSN: 2008-3645</identifier><identifier>EISSN: 2008-4161</identifier><identifier>DOI: 10.5812/jjm.17744</identifier><identifier>PMID: 25834712</identifier><language>eng</language><publisher>Iran: Ahvaz Jundishapur University of Medical Sciences</publisher><ispartof>Jundishapur journal of microbiology, 2015-02, Vol.8 (2), p.e17744-e17744</ispartof><rights>Copyright Ahvaz Jundishapur University of Medical Sciences Feb 2015</rights><rights>Copyright © 2015, Ahvaz Jundishapur University of Medical Sciences. 2015</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c403t-fd27c41451fc9194e62117bbf4f68e8bdb5ad2f16d7bd40f0964432004028ade3</citedby><cites>FETCH-LOGICAL-c403t-fd27c41451fc9194e62117bbf4f68e8bdb5ad2f16d7bd40f0964432004028ade3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4377167/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4377167/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25834712$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rahmani, Rana</creatorcontrib><creatorcontrib>Zarrini, Gholamreza</creatorcontrib><creatorcontrib>Sheikhzadeh, Farzam</creatorcontrib><creatorcontrib>Aghamohammadzadeh, Naser</creatorcontrib><title>Effective Phages as Green Antimicrobial Agents Against Antibiotic-Resistant Hospital Escherichia coli</title><title>Jundishapur journal of microbiology</title><addtitle>Jundishapur J Microbiol</addtitle><description>Bacteriophages are viruses that attack bacteria and lead to their lysis in an efficient and highly specific manner. These natural enemies of bacteria were used as therapeutic agents before the advent of antibiotics. Currently, with the rapid spread of multi-drug resistant bacteria, phage therapy can be an effective alternative treatment for antibiotic resistant bacteria.
This study evaluated the effectiveness of bacteriophages in removing antibiotic-resistant clinical Escherichia coli strains in vitro and in vivo.
Different samples were taken from bed sore and foot ulcers of patients with diabetes. E. coli strains were isolated and identified by standard methods. The antibiogram was ascertained using the Kirby Bauer disc diffusion method for ten antibiotics. The bacteriophages were isolated from environmental water samples. They were exposed to the host bacteria by the double-layer agar technique (DLA) to observe plaques. Cross reaction of the phages on test E. coli strains was performed to determine broader-spectrum phages. Phage TPR7 was selected for animal trials. Five groups of mice including a control group, bacterial group, phage group, antibiotic therapy group and phage therapy group, were examined.
Ten E. coli strains were isolated from hospital samples. They showed high resistance to the used antibiotics. An effective bacteriophage was isolated for each strain. The cross-reaction showed phages which affect more than six E. coli strains. They can be a good choice for clinical therapeutic use. In animal trials the group challenged with phages after being infected showed similar results as the group treated with gentamicin after being infected. In both groups infection was removed after 48 hours.
According to the results, six strains were resistant to six or seven antibiotics and all strains were at least resistant to two antibiotics. However, for each of these resistant bacteria one bacteriophage was isolated from environmental samples, which showed the effectiveness of bacteriophages to remove clinically resistant E. coli strains. Effective phages in vitro showed effective results in vivo as well.</description><issn>2008-3645</issn><issn>2008-4161</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNpdkU9rGzEQxUVpaUKaQ79AWeilPWyi0c5K8qVggpsUAgmhPQutdmTL7B9XkgP99pUTN7SdywzMj8ebeYy9B37RahCX2-14AUohvmKngnNdI0h4fZwbie0JO09pyw-luEbxlp2IVjeoQJwyWnlPLodHqu43dk2psqm6jkRTtZxyGIOLcxfsUC3XNOVUmg1Tyk_LLsw5uPqBUkjZTrm6mdMu5AKvkttQDG4TbOXmIbxjb7wdEp0f-xn78XX1_eqmvr27_na1vK0d8ibXvhfKIWAL3i1ggSQFgOo6j15q0l3ftbYXHmSvuh655wuJ2JRDkQtte2rO2Jdn3d2-G6l3xXK0g9nFMNr4y8w2mH83U9iY9fxosFEKpCoCn44Ccf65p5TNGJKjYbATzftkQMqFRg6oC_rxP3Q77-NUzjOgOJRAGn0Q_PxMlT-mFMm_mAFuDvmZkp95yq-wH_52_0L-Sav5Dc6klq4</recordid><startdate>20150201</startdate><enddate>20150201</enddate><creator>Rahmani, Rana</creator><creator>Zarrini, Gholamreza</creator><creator>Sheikhzadeh, Farzam</creator><creator>Aghamohammadzadeh, Naser</creator><general>Ahvaz Jundishapur University of Medical Sciences</general><general>Kowsar</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>CWDGH</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20150201</creationdate><title>Effective Phages as Green Antimicrobial Agents Against Antibiotic-Resistant Hospital Escherichia coli</title><author>Rahmani, Rana ; Zarrini, Gholamreza ; Sheikhzadeh, Farzam ; Aghamohammadzadeh, Naser</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c403t-fd27c41451fc9194e62117bbf4f68e8bdb5ad2f16d7bd40f0964432004028ade3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rahmani, Rana</creatorcontrib><creatorcontrib>Zarrini, Gholamreza</creatorcontrib><creatorcontrib>Sheikhzadeh, Farzam</creatorcontrib><creatorcontrib>Aghamohammadzadeh, Naser</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>Middle East & Africa Database</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Biological Science Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Jundishapur journal of microbiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rahmani, Rana</au><au>Zarrini, Gholamreza</au><au>Sheikhzadeh, Farzam</au><au>Aghamohammadzadeh, Naser</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effective Phages as Green Antimicrobial Agents Against Antibiotic-Resistant Hospital Escherichia coli</atitle><jtitle>Jundishapur journal of microbiology</jtitle><addtitle>Jundishapur J Microbiol</addtitle><date>2015-02-01</date><risdate>2015</risdate><volume>8</volume><issue>2</issue><spage>e17744</spage><epage>e17744</epage><pages>e17744-e17744</pages><issn>2008-3645</issn><eissn>2008-4161</eissn><abstract>Bacteriophages are viruses that attack bacteria and lead to their lysis in an efficient and highly specific manner. These natural enemies of bacteria were used as therapeutic agents before the advent of antibiotics. Currently, with the rapid spread of multi-drug resistant bacteria, phage therapy can be an effective alternative treatment for antibiotic resistant bacteria.
This study evaluated the effectiveness of bacteriophages in removing antibiotic-resistant clinical Escherichia coli strains in vitro and in vivo.
Different samples were taken from bed sore and foot ulcers of patients with diabetes. E. coli strains were isolated and identified by standard methods. The antibiogram was ascertained using the Kirby Bauer disc diffusion method for ten antibiotics. The bacteriophages were isolated from environmental water samples. They were exposed to the host bacteria by the double-layer agar technique (DLA) to observe plaques. Cross reaction of the phages on test E. coli strains was performed to determine broader-spectrum phages. Phage TPR7 was selected for animal trials. Five groups of mice including a control group, bacterial group, phage group, antibiotic therapy group and phage therapy group, were examined.
Ten E. coli strains were isolated from hospital samples. They showed high resistance to the used antibiotics. An effective bacteriophage was isolated for each strain. The cross-reaction showed phages which affect more than six E. coli strains. They can be a good choice for clinical therapeutic use. In animal trials the group challenged with phages after being infected showed similar results as the group treated with gentamicin after being infected. In both groups infection was removed after 48 hours.
According to the results, six strains were resistant to six or seven antibiotics and all strains were at least resistant to two antibiotics. However, for each of these resistant bacteria one bacteriophage was isolated from environmental samples, which showed the effectiveness of bacteriophages to remove clinically resistant E. coli strains. Effective phages in vitro showed effective results in vivo as well.</abstract><cop>Iran</cop><pub>Ahvaz Jundishapur University of Medical Sciences</pub><pmid>25834712</pmid><doi>10.5812/jjm.17744</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2008-3645 |
ispartof | Jundishapur journal of microbiology, 2015-02, Vol.8 (2), p.e17744-e17744 |
issn | 2008-3645 2008-4161 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4377167 |
source | PubMed Central Open Access; EZB-FREE-00999 freely available EZB journals; PubMed Central |
title | Effective Phages as Green Antimicrobial Agents Against Antibiotic-Resistant Hospital Escherichia coli |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T12%3A24%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effective%20Phages%20as%20Green%20Antimicrobial%20Agents%20Against%20Antibiotic-Resistant%20Hospital%20Escherichia%20coli&rft.jtitle=Jundishapur%20journal%20of%20microbiology&rft.au=Rahmani,%20Rana&rft.date=2015-02-01&rft.volume=8&rft.issue=2&rft.spage=e17744&rft.epage=e17744&rft.pages=e17744-e17744&rft.issn=2008-3645&rft.eissn=2008-4161&rft_id=info:doi/10.5812/jjm.17744&rft_dat=%3Cproquest_pubme%3E3769510201%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1701744387&rft_id=info:pmid/25834712&rfr_iscdi=true |